Reckitt Benckiser successfully wrapped up its pursuit of Schiff Nutrition on Friday with the signing of a definitive merger agreement in a deal valued at $1.4 billion. Bayer officially relinquished its proposed acquisition on the same day.
A number of smaller manufacturers of male contraceptives are launching into the market to challenge the big three: Church & Dwight (72.8% dollar share in the category), Ansell Healthcare (11.6% dollar share) and Reckitt Benckiser (11.5% dollar share).
Reckitt Benckiser on Thursday announced the retirement of Bart Becht as CEO, effective Sept. 1. Becht will be succeeded by Rakesh Kapoor, a 25-year RB veteran and current EVP global category development.